Loss of bone density and bone strength following premenopausal risk-reducing bilateral salpingo-oophorectomy: a prospective controlled study (WHAM Study)
- PMID: 32856124
- DOI: 10.1007/s00198-020-05608-5
Loss of bone density and bone strength following premenopausal risk-reducing bilateral salpingo-oophorectomy: a prospective controlled study (WHAM Study)
Abstract
Prophylactic oophorectomy is recommended for women at high risk for ovarian cancer, but the associated impact on bone health is of clinical concern. This prospective, controlled study demonstrated substantial loss of bone density and bone strength following surgical menopause. Postoperative hormone therapy alleviated, but not fully prevented, spinal bone loss.
Introduction: This prospective study investigated bone health in women following premenopausal oophorectomy.
Methods: Dual-energy x-ray absorptiometry (DXA), peripheral quantitative computed tomography (pQCT), and pQCT-based finite element analysis (pQCT-FEA) were used to assess bone health between systemic hormone therapy (HT) users and non-users after premenopausal risk-reducing bilateral salpingo-oophorectomy (RRBSO) compared with premenopausal controls over 24-month follow-up.
Results: Mean age was 42.4 ± 2.6 years (n = 30) for the surgery group and 40.2 ± 6.3 years for controls (n = 42), and baseline bone measures were similar between groups. Compromised bone variables were observed at 24 months after RRBSO, among which areal bone mineral density (aBMD) at the lumbar spine, tibial volumetric cortical density (Crt vBMD), and tibial bending stiffness (kbend) had decreased by 4.7%, 1.0%, and 12.1%, respectively (all p < 0.01). In non-HT users, significant losses in lumbar spine (5.8%), total hip (5.2%), femoral neck (6.0%) aBMD, tibial Crt vBMD (2.3%), and kbend (14.8%) were observed at 24 months (all p < 0.01). HT prevented losses in kbend, tibial Crt vBMD, and aBMD, except for modest 2.3% loss at the lumbar spine (p = 0.01).
Conclusion: This prospective, controlled study of bone health following RRBSO or premenopausal oophorectomy demonstrated substantial loss of bone density and bone strength following RRBSO. HT prevented loss of bone density and bone stiffness, although there was still a modest decrease in lumbar spine aBMD in HT users. These findings may inform decision-making about RRBSO and clinical management following premenopausal oophorectomy.
Keywords: DXA; Finite element analysis; Hormone replacement; Surgical menopause; pQCT.
Similar articles
-
Long-Term Non-Cancer Risks in People with BRCA Mutations following Risk-Reducing Bilateral Salpingo-Oophorectomy and the Role of Hormone Replacement Therapy: A Review.Cancers (Basel). 2023 Jan 24;15(3):711. doi: 10.3390/cancers15030711. Cancers (Basel). 2023. PMID: 36765666 Free PMC article. Review.
-
What Happens After Menopause? (WHAM): protocol for a prospective, multicentre, age-matched cohort trial of risk-reducing bilateral salpingo-oophorectomy in high-risk premenopausal women.BMJ Open. 2017 Nov 14;7(11):e018758. doi: 10.1136/bmjopen-2017-018758. BMJ Open. 2017. PMID: 29138210 Free PMC article.
-
What Happens After Menopause? (WHAM): A prospective controlled study of cardiovascular and metabolic risk 12 months after premenopausal risk-reducing bilateral salpingo-oophorectomy.Gynecol Oncol. 2021 Jul;162(1):88-96. doi: 10.1016/j.ygyno.2021.04.038. Epub 2021 May 7. Gynecol Oncol. 2021. PMID: 33972087
-
What happens after menopause? (WHAM): A prospective controlled study of depression and anxiety up to 12 months after premenopausal risk-reducing bilateral salpingo-oophorectomy.Gynecol Oncol. 2021 May;161(2):527-534. doi: 10.1016/j.ygyno.2021.02.001. Epub 2021 Feb 11. Gynecol Oncol. 2021. PMID: 33583580
-
The psychosexual effects of risk-reducing bilateral salpingo-oophorectomy in female BRCA1/2 mutation carriers: A systematic review of qualitative studies.Gynecol Oncol. 2021 Mar;160(3):763-770. doi: 10.1016/j.ygyno.2020.12.001. Epub 2020 Dec 11. Gynecol Oncol. 2021. PMID: 33317909
Cited by
-
Knowledge and understanding risk factors and preventive measures for osteoporosis in women: results of a survey in 502 women with and without a migration background.BMC Musculoskelet Disord. 2022 Aug 30;23(1):824. doi: 10.1186/s12891-022-05773-0. BMC Musculoskelet Disord. 2022. PMID: 36042427 Free PMC article.
-
Quantifying Bone Strength Deficits in Young Adults Born Extremely Preterm or Extremely Low Birth Weight.J Bone Miner Res. 2023 Dec;38(12):1800-1808. doi: 10.1002/jbmr.4926. Epub 2023 Nov 7. J Bone Miner Res. 2023. PMID: 37850817 Free PMC article.
-
Prevention of Ovarian Cancer: Where are We Now and Where are We Going?Curr Oncol Rep. 2024 Nov;26(11):1355-1366. doi: 10.1007/s11912-024-01587-6. Epub 2024 Aug 8. Curr Oncol Rep. 2024. PMID: 39115678 Review.
-
Long-Term Non-Cancer Risks in People with BRCA Mutations following Risk-Reducing Bilateral Salpingo-Oophorectomy and the Role of Hormone Replacement Therapy: A Review.Cancers (Basel). 2023 Jan 24;15(3):711. doi: 10.3390/cancers15030711. Cancers (Basel). 2023. PMID: 36765666 Free PMC article. Review.
-
Care after premenopausal risk-reducing salpingo-oophorectomy in high-risk women: Scoping review and international consensus recommendations.BJOG. 2023 Nov;130(12):1437-1450. doi: 10.1111/1471-0528.17511. Epub 2023 May 2. BJOG. 2023. PMID: 37132126 Free PMC article.
References
-
- Whittemore AS, Gong G, John EM, McGuire V, Li FP, Ostrow KL, Dicioccio R, Felberg A, West DW (2004) Prevalence of BRCA1 mutation carriers among U.S. non-Hispanic whites. Cancer Epidemiol Biomark Prev 13(12):2078–2083
-
- Lewis KE, Lu KH, Klimczak AM, Mok SC (2018) Recommendations and choices for BRCA mutation carriers at risk for ovarian cancer: a complicated decision. Cancers 10(2):57 - PMC
-
- Metcalfe KA, Birenbaum-Carmeli D, Lubinski J, Gronwald J, Lynch H, Moller P, Ghadirian P, Foulkes WD, Klijin J, Friedman E, Kim-Sing C, Ainsworth P, Rosen B, Domchek S, Wagner T, Tung N, Manoukian S, Couch F, Sun P, Narod SA, Heredity Breast Cancer Clinical Study Group (2008) Interventional variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers. Int J Cancer 122(9):2017–2022 - PubMed - PMC
-
- Rocca WA, Shuster LT, Grossardt BR, Maraganore DM, Geda YE, Melton LJ III (2009) Long-term effects of bilateral oophorectomy on brain aging: unanswered questions from the Mayo Clinic cohort study of oophorectomy and aging. Women's Health (Lond Engl) 5(1):39–48
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials